Foundations Investment Advisors, LLC Invitae Corp Transaction History

Foundations Investment Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 25, 2023	SELL	$1.2 - $2.73 $109 - $248	-91 Reduced 0.37%	24,687 $33,000
Q4 2022 Jan 11, 2023	SELL	$1.71 - $3.61 $7,806 - $16,479	-4,565 Reduced 15.56%	24,778 $0
Q3 2022 Oct 19, 2022	SELL	$1.9 - $8.63 $6,359 - $28,884	-3,347 Reduced 10.24%	29,343 $72,000
Q2 2022 Jul 08, 2022	SELL	$2.13 - $9.01 $2,298 - $9,721	-1,079 Reduced 3.2%	32,690 $93,000
Q1 2022 Apr 19, 2022	BUY	$6.28 - $15.59 $11,599 - $28,794	1,847 Added 5.79%	33,769 $219,000
Q4 2021 Jan 21, 2022	BUY	$14.7 - $28.67 $167,183 - $326,063	11,373 Added 55.35%	31,922 $379,000
Q3 2021 Oct 13, 2021	BUY	$24.31 - $33.6 $238,456 - $329,582	9,809 Added 91.33%	20,549 $543,000
Q2 2021 Jul 14, 2021	BUY	$26.09 - $40.4 $280,206 - $433,896	10,740 New	10,740 $343,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Foundations Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Foundations Investment Advisors, LLC with notifications on news.